cells; KC þ M-MSC group) significantly increased the MI as a dose dependent manner. Bladder capacity and micturition volume of rats in the KC group decreased significantly compared with those in the sham group. However, these parameters were reversed after transplantation of M-MSCs with every cell dosage. The bladders in the KC group exhibited markedly increased infiltration of Toluidine blue stained mast cells and a higher number of TUNEL stained apoptotic cells, compared to the sham group. The administration of M-MSCs significantly reversed the infiltration of mast cell and apoptosis detected in the KC bladders. Furthermore, M-MSC therapy helped to prevent the bladder tissue fibrosis. The gene expression analyses indicated that several genes related to tissue fibrosis, including TGF-b1 and TGF-b2, were markedly upregulated in the KC bladder. However their expression was significantly suppressed by the administration of M-MSCs. Importantly, MMSCs ameliorated the bladder function of KC rats at a low dose (1 x 10 5 ) of cells for which BM-derived MSCs did not substantially improve aberrant bladder function.
CONCLUSIONS: This study demonstrates for the first time the therapeutic efficacy of hESC-derived M-MSCs on KC in rats. The injection of M-MSCs restores bladder function with superior efficacy compared to BM-derived MSCs by protecting against the abnormal alteration in mast cell infiltration, apoptosis and fibrotic damage. Although BDNF well known to be upregulated during PBO, its role in regeneration is undisputed in the brain and other organs. We hypothesize that regulation of BDNF isoforms and doses is crucial for appropriate regeneration of bladder smooth muscle cell (BSMC).
METHODS: In Sprague-Dawley female rats, 75% of the bladder was removed (STC), while the remainder was closed with 7-0 polyglycolic acid sutures. The STC were compared to shams (n¼3,5 for 1, 7 wks), PBO (n¼5, at 7 wks) and cystotomy controls (n¼4,5 for 1, 7 wks). PBO was performed by tying a 8-0 silk ligature around 0.9 mm rod, which was then removed. Expression levels of BDNF isoforms, calponin and myosin were assayed by QPCR (delta-delta c(t) method) and indirect immunofluorescence. Scratch wounds were performed on monolayers of human BSMC in 12 well plates or chamber slides, utilizing a pipette tip and visualizing migration of cells by live cell microscopy. To test if scratch wounding increased BDNF expression, BSMC undergoing scratch or no wounds were assayed for BDNF isoforms by QPCR. To assess migration, scratch wounded BSMC were randomized to treatment with soluble BDNF receptor (TrkB) or vehicle. Exogenous BDNF was added to BSMC at 2.5, 5 and 10 ng/mL for 24-48 hours, followed by cell counting, immunofluorescence for calponin and phospho-histone3 and western blotting for myosin. RESULTS: Total BDNF was upregulated in STC (3.6-fold vs. sham at 7 weeks, p<0.035) vs PBO (>6-fold at 7 weeks, vs sham). The isoforms of BDNF were differentially regulated during STC compared to PBO, as variant1 was not upregulated in STC bladders, but was increased >370 fold during obstruction. In BSMC, 10 ng/mL BDNF decreased SMC markers calponinþmyosin, whereas at 2.5 ng/mL, it increased phosphoH3 expression, p<0.03. Similar to STC in vivo, scratch wounding increased BDNF expression mildly, at 2-fold, p<0.003. Scratch wound induced migratory behaviour in the BSMC and wound closure in the BSMC monolayers, leading to 70% wound closure at 16 hours. Migration was decreased 15% by soluble TrkB (p<0.02).
CONCLUSIONS: STC and scratch wound induce low level BDNF that increases migration and wound closure and was associated with regeneration. This work supports a role for differential effects of dose and isoforms of BDNF on bladders cells and tissue, which reflects the two-sided associations of BDNF in obstruction vs regeneration. RESULTS: Rats in the IC group showed increased voiding frequency (3.5 vs 13.8) and decreased the spot size (3.6 vs 1.2 unit) compared with sham group. Significant improvement of voiding spot pattern in frequency (4.8 and 5.1) and size (3.2 and 3.5 unit) was observed in both CHA1 and ADMSC, however, there was no difference between the two groups and the result was comparable with IALURILâ group. Histological examination revealed a significant decrease in the total number of infiltrated mast cells in CHA1 and ADMSC group compared with the IC rats, and there was no difference between the two stem cell groups. Loss of urothelial integrity and increased neutrophil infiltration in IC group was restored both in CHA1 and ADMSC group. Microarray analysis using DAVID and KEGG pathway for CHA1 cells notes several enriched pathways including, various cellular response, metabolic process, nucleic acid binding and oxidative phosphorylation.
CONCLUSIONS: CHA1 and ADMCS showed comparable therapeutic efficacy in terms of improvement of voiding pattern and histological restoration in chronic IC model. And CHA1 MSC might produce therapeutic effects through multiple mechanisms. Vol. 199, No. 4S, Supplement, Monday, May 21, 2018 THE JOURNAL OF UROLOGY â e1099
